SG11201601611WA - Systems and methods for detecting infectious diseases - Google Patents

Systems and methods for detecting infectious diseases

Info

Publication number
SG11201601611WA
SG11201601611WA SG11201601611WA SG11201601611WA SG11201601611WA SG 11201601611W A SG11201601611W A SG 11201601611WA SG 11201601611W A SG11201601611W A SG 11201601611WA SG 11201601611W A SG11201601611W A SG 11201601611WA SG 11201601611W A SG11201601611W A SG 11201601611WA
Authority
SG
Singapore
Prior art keywords
systems
methods
infectious diseases
detecting infectious
detecting
Prior art date
Application number
SG11201601611WA
Inventor
Pranav Patel
Scott Tabakman
Kamila Belhocine
Aaron Richardson
Josephine Lee
Sharada Sivaraman
Sheena Menzes
Surekha Gangakhedkar
Clarissa Lui
Elizabeth Holmes
Original Assignee
Theranos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theranos Inc filed Critical Theranos Inc
Publication of SG11201601611WA publication Critical patent/SG11201601611WA/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6846—Common amplification features
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56933—Mycoplasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/50—Other enzymatic activities
    • C12Q2521/501—Ligase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N2035/00178—Special arrangements of analysers
    • G01N2035/00237—Handling microquantities of analyte, e.g. microvalves, capillary networks
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/11—Automated chemical analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Data Mining & Analysis (AREA)
SG11201601611WA 2013-09-06 2014-09-05 Systems and methods for detecting infectious diseases SG11201601611WA (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201361874976P 2013-09-06 2013-09-06
US201361885462P 2013-10-01 2013-10-01
US201462001039P 2014-05-20 2014-05-20
US201462001053P 2014-05-21 2014-05-21
US201462010382P 2014-06-10 2014-06-10
PCT/US2014/054424 WO2015035260A1 (en) 2013-09-06 2014-09-05 Systems and methods for detecting infectious diseases

Publications (1)

Publication Number Publication Date
SG11201601611WA true SG11201601611WA (en) 2016-04-28

Family

ID=52625971

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201601611WA SG11201601611WA (en) 2013-09-06 2014-09-05 Systems and methods for detecting infectious diseases

Country Status (12)

Country Link
US (8) US9460268B2 (en)
EP (2) EP3042208A4 (en)
JP (3) JP2016537009A (en)
KR (1) KR20160053979A (en)
CN (2) CN105917235A (en)
AU (2) AU2014317990A1 (en)
BR (1) BR112016004994A2 (en)
CA (1) CA2920896A1 (en)
IL (1) IL244394A0 (en)
MX (2) MX356055B (en)
SG (1) SG11201601611WA (en)
WO (1) WO2015035260A1 (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101579327B1 (en) 2007-10-02 2015-12-21 테라노스, 인코포레이티드 Modular point-of-care devices and uses thereof
CA2825196C (en) 2011-01-21 2021-01-05 Theranos, Inc. Systems and methods for sample use maximization
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US8840838B2 (en) 2011-09-25 2014-09-23 Theranos, Inc. Centrifuge configurations
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
EP3042196A4 (en) 2013-09-06 2017-04-05 Theranos, Inc. Devices, systems, methods and kits for receiving a swab
CN105917235A (en) 2013-09-06 2016-08-31 赛拉诺斯股份有限公司 Systems and methods for detecting infectious diseases
EP3377052A4 (en) * 2015-11-17 2019-05-22 The Burlington HC Research Group, Inc. Methods for improved protection and delivery of aminothiols and analogs thereof
WO2018013579A1 (en) * 2016-07-11 2018-01-18 cARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY Sweat as a biofluid for analysis and disease identification
WO2018086023A1 (en) * 2016-11-10 2018-05-17 Coyote Bioscience Co., Ltd. Methods and systems for conducting chemical or biological reaction
WO2018111536A1 (en) 2016-12-14 2018-06-21 Becton, Dickinson And Company Methods and compositions for obtaining a tuberculosis assessment in a subject
CN106908593A (en) * 2017-03-13 2017-06-30 成都育芽科技有限公司 A kind of precisely medical protease collection device for fast detecting
US20180348218A1 (en) * 2017-06-05 2018-12-06 Tokitae Llc Serology assay for recent malaria infection
EP3435379A1 (en) * 2017-07-27 2019-01-30 Roche Diagnostics GmbH Augmenting measurement values of biological samples
US11691152B2 (en) 2017-08-31 2023-07-04 Biofire Defense, Llc Assay devices and methods of use thereof
SG11201903333SA (en) 2017-12-29 2019-08-27 Clear Labs Inc Automated priming and library loading services
CN108801677B (en) * 2018-06-27 2021-06-08 新乡医学院 Clinical examination section device platform
JP6586494B1 (en) * 2018-08-20 2019-10-02 キッコーマン株式会社 Sampling method and kit for measuring histamine
MX2021002533A (en) * 2018-09-03 2021-05-27 Visby Medical Inc Devices and methods for antibiotic susceptibility testing.
NL2021637B1 (en) * 2018-09-14 2020-05-07 Stichting Katholieke Univ Breath sampler
KR102123287B1 (en) 2018-11-07 2020-06-17 한국과학기술연구원 Evaluating adrenal steroids in saliva collected by a cotton swab
DE102019113531B4 (en) * 2019-05-21 2023-10-12 Brand Gmbh + Co Kg Control device for automatic pipetting machines
WO2020260960A1 (en) 2019-06-28 2020-12-30 Anne's Day Ltd. Vaginal detection methods and kits using a tampon
EA039422B1 (en) * 2019-09-27 2022-01-26 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) Method of detecting renal transplant infection
US11130994B2 (en) * 2019-12-13 2021-09-28 Autonomous Medical Devices Inc. Automated, cloud-based, point-of-care (POC) pathogen and antibody array detection system and method
EP4085149A4 (en) 2020-01-03 2024-03-06 Visby Medical Inc Devices and methods for antibiotic susceptibility testing
CN111187857A (en) * 2020-02-14 2020-05-22 深圳市芯思微生物科技有限公司 Primer pair, kit and preparation method and application of kit for detecting novel coronavirus through isothermal amplification
CN113376386A (en) * 2020-03-09 2021-09-10 中国科学院广州生物医药与健康研究院 Marker for viral pneumonia and application thereof
CN111349719B (en) * 2020-03-09 2020-10-20 广州医科大学附属第一医院（广州呼吸中心） Specific primer for detecting novel coronavirus and application thereof
EP4121056A4 (en) * 2020-03-19 2024-03-27 Noveome Biotherapeutics Inc Use of st266 to treat severe systemic inflammation and post-acute covid-19 syndrome
CN111088408A (en) * 2020-03-20 2020-05-01 广州凯普医药科技有限公司 Detection kit for new coronavirus, influenza A and influenza B and respiratory syncytial virus
CN111474344A (en) * 2020-03-20 2020-07-31 西安国联质量检测技术股份有限公司 Preparation method of novel coronavirus IgY antibody immunodetection reagent
CN111402347A (en) * 2020-03-20 2020-07-10 吴刚 New crown pneumonia epidemic situation prevention and control system based on Internet of things
WO2021194540A1 (en) * 2020-03-23 2021-09-30 Baseline Viral Diagnostics, Inc. Methods, systems, and a kit for detection, diagnosis, monitoring and treatment of covid-19
CN111455099B (en) * 2020-03-24 2021-12-03 武汉中帜生物科技股份有限公司 Novel coronavirus (2019-nCoV) nucleic acid detection colloidal gold chromatography kit and application thereof
CN111856004A (en) * 2020-03-25 2020-10-30 潍坊市康华生物技术有限公司 Reagent for detecting COVID-19 by chemiluminescence immunoassay and detection method thereof
CN111505282A (en) * 2020-04-21 2020-08-07 西安国联质量检测技术股份有限公司 Preparation and use methods of novel coronavirus immunofluorescence detection reagent based on IgY antibody and kit containing novel coronavirus immunofluorescence detection reagent
CN111505284B (en) * 2020-04-23 2023-05-02 中国科学院重庆绿色智能技术研究院 Test paper strip and sensor for detecting novel coronavirus SARS-CoV-2, and preparation and application thereof
WO2021236050A1 (en) 2020-05-18 2021-11-25 Baseline Global, Inc. Assay device, system, method, and kit
US11287396B2 (en) 2020-06-05 2022-03-29 Princeton Biochemicals, Inc. Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease
CN111830120B (en) * 2020-06-10 2023-06-09 北京东西分析仪器有限公司 Kit for identifying novel coronavirus by using mass spectrometry system and application method thereof
US11926877B2 (en) 2020-06-18 2024-03-12 The Board Of Trustees Of The University Of Illinois Saliva-based molecular testing for SARS-CoV-2
CN113823415A (en) * 2020-06-18 2021-12-21 香港奇岱松科技有限公司 System and application for improving health safety of people in environment against infectious diseases
US20220020481A1 (en) 2020-07-20 2022-01-20 Abbott Laboratories Digital pass verification systems and methods
WO2022018741A1 (en) 2020-07-23 2022-01-27 Indian Institute Of Technology, Kharagpur A point of care (poc) device for nucleic acid based testing and method thereof
JP6960508B1 (en) * 2020-07-29 2021-11-05 シスメックス株式会社 Methods for measuring viral antigens in samples, antibody sets and reagent kits
US11557373B2 (en) 2020-08-11 2023-01-17 Specialty Diagnostic (SDI) Laboratories, Inc. Systems and methods for smart testing of genetic materials
US11255762B1 (en) 2020-08-11 2022-02-22 Specialty Diagnostic (SDI) Laboratories, Inc. Method and system for classifying sample data for robotically extracted samples
TR202018115A2 (en) * 2020-11-12 2021-05-21 Acibadem Labmed Saglik Hizmetleri A S LABORATORY AND CLINICAL TEST METHOD FOR MONITORING T CELL RESPONSE IN DIAGNOSIS AND FOLLOW-UP OF COVID 19 DISEASE
US11430575B2 (en) 2020-11-13 2022-08-30 Specialty Diagnostic (SDI) Laboratories, Inc. Systems and methods for a data driven disease test result prediction
US11139063B1 (en) * 2020-12-29 2021-10-05 Kpn Innovations, Llc. Systems and methods for generating a microbiome balance plan for prevention of bacterial infection
US11361847B1 (en) 2021-02-06 2022-06-14 Timothy A. Hodge System and method for rapidly reporting testing results
CN113176411B (en) * 2021-03-10 2023-12-26 北京大学口腔医学院 Biomarker for detecting novel coronavirus infection by saliva and application thereof
CN113643775A (en) * 2021-07-19 2021-11-12 广西医科大学 Information acquisition method, information acquisition equipment and storage medium
CN114778656B (en) * 2022-03-29 2023-02-14 浙江苏可安药业有限公司 Serum metabolic marker for detecting drug-resistant tuberculosis and kit thereof

Family Cites Families (143)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DK171161B1 (en) 1985-03-28 1996-07-08 Hoffmann La Roche A method for detecting the presence or absence of at least one specific nucleic acid sequence in a sample or for distinguishing two different nucleic acid sequences in this sample
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4756884A (en) * 1985-08-05 1988-07-12 Biotrack, Inc. Capillary flow device
DE3920358A1 (en) 1989-06-22 1991-01-17 Behringwerke Ag BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE
WO1992001813A1 (en) 1990-07-25 1992-02-06 Syngene, Inc. Circular extension for generating multiple nucleic acid complements
JP3084733B2 (en) 1990-09-19 2000-09-04 東洋紡績株式会社 Target nucleic acid amplification method, detection method, and kit therefor
ATE207080T1 (en) 1991-11-25 2001-11-15 Enzon Inc MULTIVALENT ANTIGEN-BINDING PROTEINS
WO1994003624A1 (en) 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
US7135312B2 (en) 1993-04-15 2006-11-14 University Of Rochester Circular DNA vectors for synthesis of RNA and DNA
JPH0716094A (en) 1993-06-15 1995-01-20 Toyobo Co Ltd Production of single-stranded oligonucleotide having promoter sequence of rna polymerase
JPH0767646A (en) 1993-08-27 1995-03-14 Toyobo Co Ltd Method for amplifying nucleic acid sequence using specific rna sequence contained in sample as template
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
FR2721945B1 (en) 1994-07-04 1996-10-18 David Fabrice GENE ENHANCEMENT, A METHOD OF ISOTHERMAL GENE AMPLIFICATION AND ITS APPLICATIONS
FR2726277B1 (en) 1994-10-28 1996-12-27 Bio Merieux OLIGONUCLEOTIDE FOR USE AS PRIMER IN AN AMPLIFICATION METHOD BASED ON REPLICATION WITH MOVEMENT OF STRAND
AT402203B (en) 1995-06-13 1997-03-25 Himmler Gottfried Dipl Ing Dr METHOD FOR TRANSCRIPTION-FREE AMPLIFICATION OF NUCLEIC ACIDS
WO1997004131A1 (en) 1995-07-21 1997-02-06 Forsyth Dental Infirmary For Children Single primer amplification of polynucleotide hairpins
US20060074063A1 (en) 1995-12-29 2006-04-06 Fernandez-Pol Jose A Pharmacological agent and method of treatment
DE69739909D1 (en) 1996-03-26 2010-07-29 Michael S Kopreski METHODS USED IN PLASMA OR SERUM EXTRACTED EXTRACELLURAE RNA FOR DIAGNOSIS MONITORING OR EVALUATION OF CANCER
US6117635A (en) 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
WO1998022625A1 (en) 1996-11-20 1998-05-28 The Regents Of The University Of Michigan Microfabricated isothermal nucleic acid amplification devices and methods
WO1999004043A1 (en) 1997-07-14 1999-01-28 Abbott Laboratories Telemedicine
US6054274A (en) 1997-11-12 2000-04-25 Hewlett-Packard Company Method of amplifying the signal of target nucleic acid sequence analyte
CA2317896C (en) 1998-01-09 2004-08-10 University Of Utah Research Foundation Method for in vitro amplification of circular dna
US8445664B2 (en) 1998-06-24 2013-05-21 Enzo Diagnostics, Inc. Kits for amplifying and detecting nucleic acid sequences
US6743605B1 (en) 1998-06-24 2004-06-01 Enzo Life Sciences, Inc. Linear amplification of specific nucleic acid sequences
US6235502B1 (en) 1998-09-18 2001-05-22 Molecular Staging Inc. Methods for selectively isolating DNA using rolling circle amplification
WO2000028082A1 (en) 1998-11-09 2000-05-18 Eiken Kagaku Kabushiki Kaisha Process for synthesizing nucleic acid
RU2147123C1 (en) 1998-12-16 2000-03-27 Боев Сергей Федотович Method for examining cellular blood composition using a smear
NZ516278A (en) 1999-06-22 2004-03-26 Invitrogen Corp Improved primers and methods for the detection and discrimination of nucleic acids
US6194179B1 (en) 1999-07-20 2001-02-27 The Rockefeller University Method for preparing polynucleotide sequences and uses thereof
US6468474B2 (en) 2000-07-06 2002-10-22 Varian, Inc. Saliva testing and confirmation device
US20070087303A1 (en) 2000-12-18 2007-04-19 Tom Papanek Dental handpiece
US7993839B2 (en) 2001-01-19 2011-08-09 General Electric Company Methods and kits for reducing non-specific nucleic acid amplification
IL141392A0 (en) 2001-02-12 2002-03-10 Gene Bio Applic Ltd Orientation-directed construction of plasmids
ATE426041T1 (en) 2001-02-27 2009-04-15 Virco Bvba CIRCULAR PROBE AMPLIFICATION (CPA) OF CIRCULARIZED NUCLEIN ACID MOLECULES
US6949377B2 (en) 2001-03-05 2005-09-27 Ho Winston Z Chemiluminescence-based microfluidic biochip
US6833441B2 (en) 2001-08-01 2004-12-21 Abmaxis, Inc. Compositions and methods for generating chimeric heteromultimers
US6977148B2 (en) 2001-10-15 2005-12-20 Qiagen Gmbh Multiple displacement amplification
US7297485B2 (en) 2001-10-15 2007-11-20 Qiagen Gmbh Method for nucleic acid amplification that results in low amplification bias
US7399590B2 (en) 2002-02-21 2008-07-15 Asm Scientific, Inc. Recombinase polymerase amplification
JP3867926B2 (en) 2002-10-29 2007-01-17 独立行政法人理化学研究所 Nucleic acid amplification method
US20040209353A1 (en) 2002-12-12 2004-10-21 Chiron Corporation Biological sample storage device and method for biological sample contamination testing
US7955795B2 (en) 2003-06-06 2011-06-07 Qiagen Gmbh Method of whole genome amplification with reduced artifact production
CA3171720C (en) 2002-12-26 2024-01-09 Meso Scale Technologies, Llc. Methods for conducting electrochemiluminescence measurements
US6977153B2 (en) 2002-12-31 2005-12-20 Qiagen Gmbh Rolling circle amplification of RNA
US7309571B2 (en) 2003-02-03 2007-12-18 Ge Healthcare Bio-Sciences Corp. Amplification of self-ligated, circularized cDNA for expression profiling
JP4603547B2 (en) 2003-09-11 2010-12-22 セラノス， インコーポレイテッド Medical devices for analyte monitoring and drug delivery
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
US20050069938A1 (en) 2003-09-26 2005-03-31 Youxiang Wang Amplification of polynucleotides by rolling circle amplification
US7282333B2 (en) 2003-10-20 2007-10-16 Promega Corporation Methods and compositions for nucleic acid analysis
EP1692314A1 (en) 2003-12-10 2006-08-23 BioTrove, Inc. Improved selective ligation and amplification assay
WO2005063977A1 (en) 2003-12-25 2005-07-14 Riken Method of amplifying nucleic acid and method of detecting mutated nucleic acid using the same
WO2005095654A1 (en) 2004-03-25 2005-10-13 Biohelix Corporation Helicase-dependent amplification of circular nucleic acids
US20050220668A1 (en) 2004-04-06 2005-10-06 Bio/Data Corporation Disposable test device with sample volume measurement and mixing methods
AU2005324505B2 (en) 2004-05-13 2009-09-10 Nanobiosym, Inc. Nano-PCR: methods and devices for nucleic acid amplification and detection
JP2005333920A (en) 2004-05-28 2005-12-08 Aisin Seiki Co Ltd Method for amplifying template dna molecule by using isothermally amplifiable strand displacement dna polymerase
US20060040300A1 (en) 2004-08-09 2006-02-23 Generation Biotech, Llc Method for nucleic acid isolation and amplification
US20060194214A1 (en) 2005-02-28 2006-08-31 George Church Methods for assembly of high fidelity synthetic polynucleotides
JP5068175B2 (en) 2005-01-04 2012-11-07 日立化成工業株式会社 Primer-generated rolling circle amplification
US8614101B2 (en) 2008-05-20 2013-12-24 Rapid Pathogen Screening, Inc. In situ lysis of cells in lateral flow immunoassays
GB0504774D0 (en) 2005-03-08 2005-04-13 Lingvitae As Method
WO2006119066A2 (en) 2005-04-29 2006-11-09 The J. Craig Venter Institute Amplification and cloning of single dna molecules using rolling circle amplification
MX340077B (en) * 2005-05-09 2016-06-24 Theranos Inc Point-of-care fluidic systems and uses thereof.
CA2621146A1 (en) 2005-09-06 2007-03-15 Gen-Probe Incorporated Methods, compositions and kits for isothermal amplification of nucleic acids
WO2007078850A2 (en) 2005-12-29 2007-07-12 I-Stat Corporation Molecular diagnostics amplification system and methods
US8741230B2 (en) 2006-03-24 2014-06-03 Theranos, Inc. Systems and methods of sample processing and fluid control in a fluidic system
US8007999B2 (en) * 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
US7972786B2 (en) 2006-07-07 2011-07-05 Brandeis University Detection and analysis of influenza virus
GB0614825D0 (en) 2006-07-26 2006-09-06 Medical Res Council Method for amplification of ligation reactions
GB0618046D0 (en) 2006-09-13 2006-10-25 Lingvitae As Method
US20110001036A1 (en) * 2006-10-24 2011-01-06 Koninklijke Philips Electronics N.V. system for imaging an object
US7910302B2 (en) * 2006-10-27 2011-03-22 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US20080153096A1 (en) 2006-11-02 2008-06-26 Vectrant Technologies Inc. Cartridge for conducting diagnostic assays
US20100323404A1 (en) * 2007-02-09 2010-12-23 Richard Lathrop Method for recombining dna sequences and compositions related thereto
GB0706281D0 (en) * 2007-03-30 2007-05-09 Guy S And St Thomas Nhs Founda Apparatus and method for recovering fluid from a fluid absorbing element
US8133671B2 (en) * 2007-07-13 2012-03-13 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
US8435741B2 (en) 2007-07-26 2013-05-07 Fujifilm Corporation Isothermal nucleic acid amplification method using surfactant
GB0715171D0 (en) 2007-08-03 2007-09-12 Enigma Diagnostics Ltd Sample processor
US8158430B1 (en) 2007-08-06 2012-04-17 Theranos, Inc. Systems and methods of fluidic sample processing
JP2009048280A (en) 2007-08-15 2009-03-05 Nikon Corp Mechanism analysis program
KR101579327B1 (en) * 2007-10-02 2015-12-21 테라노스, 인코포레이티드 Modular point-of-care devices and uses thereof
KR101414713B1 (en) 2007-10-11 2014-07-03 삼성전자주식회사 Method of amplifying target nucleic acids by rolling circle amplification in the presence of ligase and endonuclease
US8420323B2 (en) 2007-11-14 2013-04-16 Fujifilm Corporation Nucleic acid amplification method
US8034568B2 (en) * 2008-02-12 2011-10-11 Nugen Technologies, Inc. Isothermal nucleic acid amplification methods and compositions
WO2009120374A2 (en) 2008-03-28 2009-10-01 Pacific Biosciences Of California, Inc. Methods and compositions for nucleic acid sample preparation
PL2660336T3 (en) 2008-06-11 2017-12-29 Orion Pharma (Uk) Limited Isothermal nucleic acid amplification
US7863222B2 (en) 2008-08-01 2011-01-04 Rigel Pharmaceuticals, Inc. shRNA library
CN102272327B (en) 2008-11-07 2015-11-25 赛昆塔公司 By the method for sequential analysis monitoring situation
JP5616584B2 (en) 2009-01-09 2014-10-29 富士フイルム株式会社 Nucleic acid sequence replication method
CN102341506A (en) * 2009-01-21 2012-02-01 沃泰克斯药物股份有限公司 Methods for amplifying hepatitis c virus nucleic acids
GB0910302D0 (en) 2009-06-15 2009-07-29 Lumora Ltd Nucleic acid amplification
KR101875858B1 (en) 2009-10-19 2018-07-06 테라노스, 인코포레이티드 Integrated health data capture and analysis system
US9499860B2 (en) 2010-02-19 2016-11-22 The Ohio State University Primers and methods for nucleic acid amplification
GB201013153D0 (en) 2010-08-04 2010-09-22 Touchlight Genetics Ltd Primer for production of closed linear DNA
CN101906488B (en) 2010-08-09 2012-10-24 宁波大学 Method for detecting infectious spleen and kidney necrosis viruses by using hyper-branched rolling circle amplification
WO2012038049A2 (en) * 2010-09-22 2012-03-29 Roche Diagnostics Gmbh Amplification of distant nucleic acid targets using engineered primers
US10392726B2 (en) 2010-10-08 2019-08-27 President And Fellows Of Harvard College High-throughput immune sequencing
WO2012075506A2 (en) 2010-12-03 2012-06-07 Beth Israel Deaconess Medical Center, Inc. Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
CA2825196C (en) 2011-01-21 2021-01-05 Theranos, Inc. Systems and methods for sample use maximization
WO2013003585A2 (en) 2011-06-29 2013-01-03 The Johns Hopkins University Enrichment of nucleic acids by complimentary capture
AU2012279420A1 (en) * 2011-07-06 2014-01-30 Advanced Liquid Logic Inc Reagent storage on a droplet actuator
WO2013035875A1 (en) 2011-09-08 2013-03-14 独立行政法人理化学研究所 Primer set, method for amplifying target nucleic acid sequence using same, and method for detecting mutated nucleic acid using same
US8435738B2 (en) * 2011-09-25 2013-05-07 Theranos, Inc. Systems and methods for multi-analysis
US20130080071A1 (en) 2011-09-25 2013-03-28 Theranos, Inc., a Delaware Corporation Systems and methods for sample processing and analysis
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US20140170735A1 (en) * 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US8840838B2 (en) 2011-09-25 2014-09-23 Theranos, Inc. Centrifuge configurations
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US20130074614A1 (en) 2011-09-25 2013-03-28 Theranos, Inc., a Delaware Corporation Container configurations
US8380541B1 (en) 2011-09-25 2013-02-19 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
RU2627927C2 (en) 2011-09-25 2017-08-14 Теранос, Инк. Systems and methods for multiparameter analysis
US9810704B2 (en) * 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US10012664B2 (en) * 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
US20140335505A1 (en) 2011-09-25 2014-11-13 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US20140308661A1 (en) 2011-09-25 2014-10-16 Theranos, Inc. Systems and methods for multi-analysis
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US11249799B2 (en) 2011-09-26 2022-02-15 Labrador Diagnostics Llc Methods, systems, and devices for real time execution and optimization of concurrent test protocols on a single device
WO2013053855A1 (en) 2011-10-11 2013-04-18 Qiagen Gmbh Sample processing method and sample processing cartridge
KR101329563B1 (en) 2011-12-13 2013-11-15 연세대학교 산학협력단 Devices for Extracting Body Fluid
US9389229B2 (en) 2012-07-18 2016-07-12 Theranos, Inc. Methods for detecting and measuring aggregation
CN104640637B (en) * 2012-07-18 2018-09-18 赛拉诺斯知识产权有限责任公司 High-speed micro centrifugator for small samples method
EP2692870A1 (en) 2012-08-03 2014-02-05 Alacris Theranostics GmbH Method for nucleic acid amplification
US9809845B2 (en) 2012-08-06 2017-11-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and reagents for amplifying nucleic acids
KR20150055002A (en) 2012-09-11 2015-05-20 테라노스, 인코포레이티드 Information management systems and methods using a biological signature
US9476089B2 (en) 2012-10-18 2016-10-25 President And Fellows Of Harvard College Methods of making oligonucleotide probes
US20140342371A1 (en) 2012-12-05 2014-11-20 Theranos, Inc. Bodily Fluid Sample Collection and Transport
US9051599B2 (en) 2012-12-10 2015-06-09 Theranos, Inc. Rapid, low-sample-volume cholesterol and triglyceride assays
US20140170678A1 (en) 2012-12-17 2014-06-19 Leukodx Ltd. Kits, compositions and methods for detecting a biological condition
US9359632B2 (en) 2013-03-15 2016-06-07 Theranos, Inc. Devices, systems and methods for sample preparation
EP3564370B1 (en) 2013-03-15 2022-01-12 Labrador Diagnostics LLC Nucleic acid amplification
US9416387B2 (en) 2013-03-15 2016-08-16 Theranos, Inc. Nucleic acid amplification
CA2906805A1 (en) 2013-03-15 2014-09-18 Theranos, Inc. Nucleic acid amplification
US9290800B2 (en) 2013-03-15 2016-03-22 Pacific Biosciences Of California, Inc. Targeted rolling circle amplification
US10450595B2 (en) 2013-03-15 2019-10-22 Theranos Ip Company, Llc Nucleic acid amplification
EP3042196A4 (en) 2013-09-06 2017-04-05 Theranos, Inc. Devices, systems, methods and kits for receiving a swab
CN105917235A (en) 2013-09-06 2016-08-31 赛拉诺斯股份有限公司 Systems and methods for detecting infectious diseases

Also Published As

Publication number Publication date
US9916428B2 (en) 2018-03-13
JP2019213534A (en) 2019-12-19
US10522245B2 (en) 2019-12-31
JP2016537009A (en) 2016-12-01
US20150072889A1 (en) 2015-03-12
MX2018005873A (en) 2022-11-17
CA2920896A1 (en) 2015-03-12
US20170168051A1 (en) 2017-06-15
AU2014317990A1 (en) 2016-02-25
EP3674422A3 (en) 2020-09-16
JP2022002529A (en) 2022-01-11
US9529976B2 (en) 2016-12-27
CN111378568A (en) 2020-07-07
IL244394A0 (en) 2016-04-21
US20160070884A1 (en) 2016-03-10
US9460268B2 (en) 2016-10-04
MX2016002855A (en) 2016-06-22
US20150072338A1 (en) 2015-03-12
CN105917235A (en) 2016-08-31
AU2018202249A1 (en) 2018-04-26
MX356055B (en) 2018-05-11
US20150299777A1 (en) 2015-10-22
EP3674422A2 (en) 2020-07-01
US10283217B2 (en) 2019-05-07
US20160245810A1 (en) 2016-08-25
EP3042208A1 (en) 2016-07-13
WO2015035260A1 (en) 2015-03-12
US20200013488A1 (en) 2020-01-09
KR20160053979A (en) 2016-05-13
BR112016004994A2 (en) 2021-05-11
US20200234804A1 (en) 2020-07-23
EP3042208A4 (en) 2017-04-19

Similar Documents

Publication Publication Date Title
IL244394A0 (en) Systems and methods for detecting infectious diseases
HK1221195A1 (en) Systems and methods for sensing objects
HK1226158A1 (en) Methods and system for detecting sequence variants
HK1223153A1 (en) Systems and methods for infrared detection
HK1220161A1 (en) Diagnostic systems and methods
IL243760A0 (en) Systems and methods for a distributed clinical laboratory
GB2534093B (en) Systems and methods for improved accuracy
HK1225414B (en) Method and system for sensing
SG11201604923XA (en) Methods and systems for detecting genetic variants
EP2946345A4 (en) Methods and systems for genetic analysis
EP2962268A4 (en) Systems and methods for improving clinical documentation
SG11201506246WA (en) Ranging and positioning system
EP2959403A4 (en) Link association analysis systems and methods
IL242834A (en) Wheelchair curb-climbing and curb-descending system
GB201315185D0 (en) Location detection system and method
GB201409951D0 (en) Object detection system
EP2998901A4 (en) Unauthorized-access detection system and unauthorized-access detection method
ZA201601263B (en) Proximity detection systems and methods
IL240089A0 (en) System and method for counting zooplankton
GB201409953D0 (en) Object detection system
GB2511755B (en) Event Detection
EP2973393A4 (en) Methods and systems for structural analysis
SG11201605181RA (en) Miniaturized system for confined detection and location
EP2967491A4 (en) Methods and systems for characterizing an object
SG2013055744A (en) Improved detection system